Bayer is alleging Abbott infringed on a patent with its autoimmune treatment, according to published reports Monday. More: continued here
Bayer is alleging Abbott infringed on a patent with its autoimmune treatment, according to published reports Monday. More: continued here
The company has already surpassed its initial goals of selling $150 million of non-core assets by mid-2009. More: continued here
Apple investors react to another blog report about Steve Jobs’ health, and can you really blame them? More: continued here
Did your 401k lose value or are you afraid to invest in the stock market? If so, you may want to make a stop at your local high school economics class. More: continued here
Someone is potentially bottom-fishing after the declines that RIG has suffered. More: continued here
GMAC’s $6 billion federal investment makes the prospects for several less controversial applicants to receive government funds brighter. More: continued here
The buyout unites two painkiller makers, enhancing King’s market presence. More: continued here
According to the company, the 2009-2010 plan is expected to save hundreds of megawatts and hundreds of millions of dollars. More: continued here
Weakness in the carpet industry is forcing the company to make cuts. More: continued here
AnnTaylor’s been downgraded, while Ultralife’s been upgraded. Here’s why, as well as updates on several other stocks. More: continued here